Does Myectomy Convey Survival Benefit in Hypertrophic Cardiomyopathy?

Heart Failure Clinics

Volumn 3, Issue 3, 2007, Pages 275-288

  Woo, Anna ^a   Rakowski, Harry ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

CLINICAL STUDY; COMPARATIVE STUDY; COMPREHENSION; CONSERVATIVE TREATMENT; DEATH; DISEASE COURSE; ECHOCARDIOGRAPHY; EXPERIENCE; FOLLOW UP; HEALTH CENTER; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART PACING; HISTORY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTERVENTION STUDY; LEARNING; MORBIDITY; MORTALITY; MUSCLE RESECTION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PREVALENCE; PROGNOSIS; REVIEW; RISK; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL; SURVIVAL TIME; SYMPTOM; TRANSAORTIC SEPTAL MYECTOMY; TREATMENT OUTCOME;

CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHY, HYPERTROPHIC; CAUSE OF DEATH; HEART SEPTUM; HUMANS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 34548177525     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2007.04.010     Document Type: Review

References (78)

1. Brock R. Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis). Guys Hosp Rep 106 (1957) 221-238
2. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 20 (1958) 1-8
3. Maron B.J., McKenna W.J., Danielson G.K., et al. Task force on clinical expert consensus documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 (2003) 1687-1713
4. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
5. Goodwin J.F., Hollman A., Cleland W.P., et al. Obstructive cardiomyopathy simulating aortic stenosis. Br Heart J 22 (1960) 403-414
6. Braunwald E., Lambrew C.T., Rockoff S.D., et al. Idiopathic hypertrophic subaortic stenosis: I. A description of the disease based on an analysis of 64 patients. Circulation 30 Suppl 4 (1964) 3-119
7. Goodwin J.F. An appreciation of hypertrophic cardiomyopathy. Am J Med 68 (1980) 797-800
8. Canedo M.I., and Frank M.J. Therapy of hypertrophic cardiomyopathy: medical or surgical? Clinical and pathophysiologic considerations. Am J Cardiol 48 (1981) 383-387
9. Rakowski H., Sasson Z., and Wigle E.D. Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy. J Am Soc Echocardiogr 1 (1988) 31-47
10. Wigle E.D., Adelman A.G., Auger P., et al. Mitral regurgitation in muscular subaortic stenosis. Am J Cardiol 24 (1969) 698-706
11. Grigg L.E., Wigle E.D., Williams W.G., et al. Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making. J Am Coll Cardiol 20 (1992) 42-52
12. Maron B.J., Dearani J.A., Ommen S.R., et al. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 2044-2053
13. Maron M.S., Olivotto I., Betocchi S., et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
14. Elliott P.M., Gimeno J.R., Tome M.T., et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 27 (2006) 1933-1941
15. Frank S., and Braunwald E. Idiopathic hypertrophic subaortic stenosis: clinical analysis of 126 patients with emphasis on the natural history. Circulation 37 (1968) 759-788
16. Adelman A.G., Wigle E.D., Ranganathan N., et al. The clinical course in muscular subaortic stenosis: a retrospective and prospective study of 60 hemodynamically proved cases. Ann Intern Med 77 (1972) 515-525
17. Hardarson T., De la Calzada C.S., Curiel R., et al. Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 2 (1973) 1462-1467
18. Shah P.M., Adelman A.G., Wigle E.D., et al. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy: a multicenter study. Circ Res 34 and 35 Suppl II (1974) II179-II195
19. Spirito P., Chiarella F., Carratino L., et al. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 320 (1989) 749-755
20. Cecchi F., Olivotto I., Montereggi A., et al. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 26 (1995) 1529-1536
21. Maron B.J., Casey S.A., Poliac L.C., et al. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 281 (1999) 650-655
22. Morrow A.G., and Brockenbrough E.C. Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy. Ann Surg 154 (1961) 181-189
23. Kirklin J.W., and Ellis Jr. F.H. Surgical relief of diffuse subvalvular aortic stenosis. Circulation 24 (1961) 739-742
24. Wigle E.D., Chrysohou A., and Bigelow W.G. Results of ventriculomyotomy in muscular subaortic stenosis. Am J Cardiol 11 (1963) 572-586
25. Lillehei C.W., and Levy M.J. Transatrial exposure for correction of subaortic stenosis. J Am Med Assoc 1686 (1963) 8-13
26. Cooley D.A., Bloodwell R.D., Hallman G.L., et al. Surgical treatment of muscular subaortic stenosis: results from septectomy in twenty-six patients. Circulation 35 Suppl 1 (1967) 124-132
27. Wigle E.D., Trimble A.S., Adelman A.G., et al. Surgery in muscular subaortic stenosis. Prog Cardiovasc Dis 11 (1968) 83-112
28. Cleland W.P. The surgical management of obstructive cardiomyopathy. J Cardiovasc Surg 4 (1963) 489-491
29. Bentall H.H., Cleland W.P., Oakley C.M., et al. Surgical treatment and post-operative haemodynamic studies in hypertrophic obstructive cardiomyopathy. Br Heart J 27 (1965) 585-594
30. Morrow A.G., Lambrew C.T., and Braunwald E. Idiopathic hypertrophic subaortic stenosis: II. Operative treatment and the results of pre- and postoperative hemodynamic evaluations. Circulation 30 Suppl IV (1964) 120-151
31. Bigelow W.G., Trimble A.S., Auger P., et al. The ventriculomyotomy operation for muscular subaortic stenosis. J Thorac Cardiovasc Surg 52 (1966) 514-524
32. Morrow A.G., Fogarty T.J., Hannah III H., et al. Operative treatment in idiopathic hypertrophic subaortic stenosis: techniques and the results of preoperative and postoperative clinical and hemodynamic assessments. Circulation 37 (1968) 589-596
33. Morrow A.G. Hypertrophic subaortic stenosis: operative methods utilized to relieve left ventricular outflow obstruction. J Thorac Cardiovasc Surg 76 (1978) 423-430
34. Cooley D.A., Leachman R.D., and Wukasch D.C. Diffuse muscular subaortic stenosis: surgical treatment. Am J Cardiol 31 (1973) 1-6
35. McIntosh C.L., and Maron B.J. Current operative treatment of obstructive hypertrophic cardiomyopathy. Circulation 78 (1988) 487-495
36. Cohen L.S., and Braunwald E. Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade. Circulation 35 (1967) 847-851
37. Flamm M.D., Harrison D.C., and Hancock E.W. Muscular subaortic stenosis: prevention of outflow obstruction with propranolol. Circulation 38 (1968) 848-858
38. Frank M.J., Abdulla A.M., Canedo M.I., et al. Long-term medical management of hypertrophic obstructive cardiomyopathy. Am J Cardiol 42 (1978) 993-1001
39. Tajik A.J., Guiliani E.R., Weidman W.H., et al. Idiopathic hypertrophic subaortic stenosis: long-term surgical follow-up. Am J Cardiol 34 (1974) 815-822
40. Maron B.J., Merrill W.H., Freier P.A., et al. Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation 57 (1978) 1205-1213
41. Goodwin J.F., and Oakley C.M. Medical and surgical treatment of hypertrophic cardiomyopathy. Eur Heart J 4 Suppl F (1983) 209-214
42. Maron B.J., Epstein S.E., and Morrow A.G. Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy. Eur Heart J 4 Suppl F (1983) 175-185
43. Mohr R., Schaff H.V., Danielson G.K., et al. The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy: experience over 15 years. J Thorac Cardiovasc Surg 97 (1989) 666-674
44. Schulte H.D., Bircks W.H., Loesse B., et al. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. J Thorac Cardiovasc Surg 106 (1993) 709-717
45. Schulte H.D., Borisov K., Gams E., et al. Management of symptomatic hypertrophic obstructive cardiomyopathy-long-term results after surgical therapy. Thorac Cardiovasc Surg 47 (1999) 213-218
46. Cohn L.H., Trehan H., and Collins J.J. Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 70 (1992) 657-660
47. Ten Berg J.M., Suttorp M.J., Knaepan P.J., et al. Hypertrophic obstructive cardiomyopathy: initial results and long-term follow up after Morrow septal myectomy. Circulation 90 (1994) 1781-1785
48. Heric B., Lytle B.W., Millder D.P., et al. Surgical management of hypertrophic obstructive cardiomyopathy. J Thorac Cardovasc Surg 110 (1995) 195-208
49. Schoendube F.A., KLues H.G., Reith S., et al. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation 92 Suppl 2 (1995) II122-II127
50. Robbins R.C., and Stinson E.B. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 111 (1996) 586-594
51. Schonbeck M.H., Brunner-La Rocca H.P., Vogt P.R., et al. Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. Ann Thorac Surg 65 (1998) 1207-1214
52. Woo A., Williams W.G., Choi R., et al. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 111 (2005) 2033-2041
53. Ommen S.R., Maron B.J., Olivotto I., et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 46 (2005) 470-476
54. Marwick T.H., Stewart W.J., Lever H.M., et al. Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy. J Am Coll Cardiol 20 (1992) 1066-1072
55. Ommen S., Park S.H., Click R.L., et al. Impact of intraoperative transesophageal echocardiography in the surgical management of hypertrophic cardiomyopathy. Am J Cardiol 90 (2002) 1022-1024
56. Morrow A.G., Koch J.P., Maron B.J., et al. Left ventricular myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy and previous cardiac arrest. Am J Cardiol 46 (1980) 313-316
57. Rothlin M.E., Gobet D., Haberer T., et al. Surgical treatment versus medical treatment in hypertrophic obstructive cardiomyopathy. Eur Heart J 4 Suppl F (1983) 215-223
58. Seiler C., Hess O.M., Schoenbeck M., et al. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol 17 (1991) 634-642
59. Watkins H., and McKenna W.J. The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy (Editorial Comment). J Am Coll Cardiol 46 (2005) 477-479
60. Fananapazir L., Cannon R.O., Tripodi D., et al. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and β-adrenergic blocker therapy. Circulation 85 (1992) 2149-2161
61. Fananapazir L., Epstein N.D., Curiel R.V., et al. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 90 (1994) 2731-2742
62. Nishimura R.A., Trusty J.M., Hayes D.L., et al. Dual-chamber pacing for patients with hypertrophic obstructive cardiomyopathy: a prospective randomized, double-blind cross-over study. J Am Coll Cardiol 29 (1997) 435-441
63. Kappenberger L., Linde C., Daubert C., et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. Eur Heart J 18 (1997) 1249-1256
64. Maron B.J., Nishimura R.A., McKenna W.J., et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, cross-over study (M-PATHY). Circulation 99 (1999) 2927-2933
65. Ommen S.R., Nishimura R.A., Squires R.W., et al. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 34 (1999) 191-196
66. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346 (1995) 211-214
67. Flores-Ramirez R., Lakkis N.M., Middleton K.J., et al. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 37 (2001) 208-214
68. Faber L., Seggewiss H., and Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation 98 (1998) 2415-2421
69. Monakier D., Woo A., Vannan M.A., et al. Myocardial contrast echocardiography in chronic ischemic and nonischemic cardiomyopathies. Cardiol Clin 22 (2004) 269-282
70. Nagueh S.F., Ommen S.R., Lakkis N.M., et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 38 (2001) 1701-1706
71. Qin J.X., Shiota T., Lever H.M., et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 38 (2001) 1994-2000
72. Firoozi S., Elliott P.M., Sharma S., et al. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy: a comparison of clinical, haemodynamic and exercise outcomes. Eur Heart J 23 (2002) 1617-1624
73. Ralph-Edwards A., Woo A., McCrindle B.W., et al. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg 129 (2005) 351-358
74. van der Lee C., ten Cate F.J., Geleijnse M.L., et al. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets. Circulation 112 (2005) 482-488
75. Seggewiss H., Faber L., and Gleichmann U. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg 47 (1999) 94-100
76. Fernandes V.L., Nagueh S.F., Wang W., et al. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy-the Baylor experience (1996-2002). Clin Cardiol 28 (2005) 124-130
77. Wigle E.D., Schwartz L., Woo A., et al. To ablate or to operate: that is the question!. J Am Coll Cardiol 38 (2001) 1707-1710
78. Knight C.J. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Heart 92 (2006) 1339-1344